Kaplan–Meier analysis showed that patients having a cRCC without cytoplasmic expression of IL1β protein have a shorter disease-free survival compared to those with cytoplasmic IL1β expression (Fig. 3B). The gene discussed is IL1B; the disease is chromophobe renal cell carcinoma.